NEW YORK, Sept. 29, 2017 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Depomed, Inc. (NASDAQ:DEPO) from February 26, 2015 through August 7, 2017, inclusive (the “Class Period”) of the important October 17, 2017 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Depomed investors under the federal securities laws.
To join the Depomed class action, go to http://rosenlegal.com/cases-1185.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Depomed engaged in questionable practices in connection with the sales and marketing of the Company’s opioid products; (2) the foregoing conduct, when it became known, would likely subject the Company to heightened legal and regulatory scrutiny; and (3) as a result, Depomed’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 17, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1185.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com


China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
OpenAI Addresses Security Vulnerability in macOS App Certification Process
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home 



